FDA Approves New Targeted Therapy Drug Combination for Lung Cancer
The US Food and Drug Administration (FDA) has approved the targeted therapy drugs Tafinlar (dabrafenib) and Mekinist (trametinib) to be used together to treat people with a specific type of non-small cell lung cancer that has spread in the body (metastasized).
Tobacco Use Drops Among Middle and High School Students
The number of middle and high school students in the US who use tobacco dropped from 4.7 million in 2015 to 3.9 million in 2016 according to a report from the US Centers for Disease Control and Prevention and the US Food and Drug Administration’s Center for Tobacco Products.
Study: Cancer Patients Lived Longer Using Tool to Report Symptoms
Researchers from several US cancer centers have found that patients who used an online tool to report symptoms to their cancer care team lived an average of 5 months longer than patients who did not use the tool.
Cancer Specialists Gather to Discuss Innovations in Research and Treatment
More than 30,000 cancer specialists from around the world are gathering in Chicago this week for the 53rd annual meeting of the American Society of Clinical Oncology (ASCO).
Rare Cancers Present Unique Challenges
About 1 in 5 cancer diagnoses in the US is for a rare cancer, according to a report prepared by American Cancer Society researchers.